FACTIVE- gemifloxacin mesylate tablet United States - English - NLM (National Library of Medicine)

factive- gemifloxacin mesylate tablet

merus labs international inc. - gemifloxacin mesylate (unii: x4s9f8rl01) (gemifloxacin - unii:okr68y0e4t) - gemifloxacin 320 mg - factive is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below. (see dosage and administration and clinical studies. ) acute bacterial exacerbation of chronic bronchitis (abecb) caused by streptococcus pneumoniae, haemophilus influenzae, haemophilus parainfluenzae, or moraxella catarrhalis . because fluoroquinolones, including factive, have been associated with serious adverse reactions (see warnings ) and for some patients abecb is self-limiting, reserve factive for treatment of abecb in patients who have no alternative treatment options. community-acquired pneumonia (of mild to moderate severity) caused by streptococcus pneumoniae (including multi-drug resistant strains [mdrsp])*, haemophilus influenzae, moraxella catarrhalis, mycoplasma pneumoniae, chlamydia pneumoniae, or klebsiella pneumoniae . *mdrsp: multi-drug resistant s

Nitrocine 1 mg/ml solution for infusion, ampoule Ireland - English - HPRA (Health Products Regulatory Authority)

nitrocine 1 mg/ml solution for infusion, ampoule

merus labs luxco ii s.à.r.l. - glyceryl trinitrate - solution for infusion - 1 milligram(s)/millilitre - organic nitrates; glyceryl trinitrate

Nitrocine 1 mg/ml solution for infusion, vial Ireland - English - HPRA (Health Products Regulatory Authority)

nitrocine 1 mg/ml solution for infusion, vial

merus labs luxco ii s.à.r.l. - glyceryl trinitrate - solution for infusion - 1 milligram(s)/millilitre - organic nitrates; glyceryl trinitrate

Emselex 7.5mg modified-release tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

emselex 7.5mg modified-release tablets

merus labs luxco s.a r.l. - darifenacin hydrobromide - modified-release tablet - 7.5mg

Emselex 15mg modified-release tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

emselex 15mg modified-release tablets

merus labs luxco s.a r.l. - darifenacin hydrobromide - modified-release tablet - 15mg

Isoket 1mg/ml Concentrate for solution for injection or infusion, 10 ml Ampoule Ireland - English - HPRA (Health Products Regulatory Authority)

isoket 1mg/ml concentrate for solution for injection or infusion, 10 ml ampoule

merus labs luxco ii s.à.r.l. - isosorbide dinitrate - concentrate for solution for injection/infusion - 1 milligram(s)/millilitre - organic nitrates; isosorbide dinitrate

Elantan 20 mg Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

elantan 20 mg tablets

merus labs luxco ii s.à.r.l. - isosorbid-5-mononitrat - tablet - 20 milligram(s) - organic nitrates; isosorbide mononitrate

Elantan 40 mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

elantan 40 mg tablets

merus labs luxco ii s.à.r.l. - isosorbid-5-mononitrat - tablet - 40 milligram(s) - organic nitrates; isosorbide mononitrate

Elantan 10 mg Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

elantan 10 mg tablets

merus labs luxco ii s.à.r.l. - isosorbide mononitrate - tablet - 10 milligram(s) - organic nitrates; isosorbide mononitrate

Elantan LA 25mg Prolonged Release Capsules Ireland - English - HPRA (Health Products Regulatory Authority)

elantan la 25mg prolonged release capsules

merus labs luxco ii s.à.r.l. - isosorbide mononitrate - prolonged-release capsule, hard - 25 milligram(s) - organic nitrates; isosorbide mononitrate